Overview: Rubella IgG TestIntroduction: The Rubella IgG Test detects rubella IgG to confirm immunity, preventing congenital defects. Aligned with 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding vaccination planning and improving outcomes in serology for patients, especially pregnant women, to prevent congenital rubella syndrome.
Other Names: Rubella IgG Assay, Rubella Immunity Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Rubella IgG testing began in the 1960s with rubella vaccine development. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects rubella IgG to confirm immunity, guides vaccination, and prevents congenital defects.
Test Parameters: 1. Rubella IgG Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of vaccination or rubella exposure.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document vaccination history, rubella exposure, or pregnancy status. Include current medications, especially immunosuppressants.
Consent: Written consent required, detailing the tests purpose, rubella immunity implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to detect rubella IgG antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for rubella immunity screening.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Immunosuppression may reduce antibody detection.
Clinical Significance: Positive rubella IgG confirms immunity, guiding pregnancy management or vaccination. Negative results indicate need for vaccination.
Specialist Consultation: Consult an obstetrician or infectious disease specialist for result interpretation and vaccination planning.
Additional Supporting Tests: Rubella IgM, vaccination history, or clinical evaluation to confirm immunity status.
Test Limitations: Non-specific for recent infection; clinical correlation is needed. Sample quality affects sensitivity.
References: CDC Rubella Guidelines, 2023; Journal of Infectious Diseases, Reef SE, 2022.
